The US Department of Health and Human Services’ Office for Civil Rights has levied big fines against medical organizations who failed to adhere to HIPAA requirements to release medical records to patients at their request.
The COVID-19 pandemic has served as a catalyst for clinicians who previously put off purchasing insurance.
When talking about work issues, Dr Bernstein recommends trying not to focus too much on how awful things are because it can be disheartening.
Phase 2 clinical trial shows promising result for dabrafenib and trametinib combination in patients with advanced cholangiocarcinoma with a BRAFV600E mutation.
A team of researchers recently evaluated serum concentrations of persistent organic pollutants to determine how they may affect celiac disease.
Researchers reviewed the clinical/pathologic aspects of HSTCL and summarized the latest molecular studies and potential novel therapeutic targets.
Practices need to know all of the components of their health information systems to determine potential vulnerabilities.
A team of investigators conducted a systematic review and meta-analysis to assess the risk of extraintestinal cancer in patients with inflammatory bowel disease.
Meeting public demand for an urgently needed effective medication quickly and safely during a pandemic involves difficult tradeoffs.
By connecting on a personal level, medical practices may have better results in getting patients to settle their accounts.
Artificial intelligence has led to the development of promising improvements in colorectal cancer screening.
Gastroenterologists are more frequently encountering cannabinoid hyperemesis syndrome in both inpatient and outpatient settings.
Diagnostic testing can inform decision-making on whether to conduct endoscopy operations during a pandemic.
COVID-19 has brought unprecedented stress to society at large and perhaps most of all to frontline healthcare teams in a variety of settings. We spoke to an expert about teamwork during such trying times.
Hackers have penetrated healthcare providers’ computer systems to encrypt information and demand money for its release.
It remains important to interrogate how structural discrimination influences the collection of patient-reported outcomes.
A team of investigators assessed the potential for use of proton pump inhibitors to affect the risk of COVID-19 infection.
As the role of the gut microbiome in nonalcoholic fatty liver disease is explored, research has turned to fecal microbiota transplantation as a potential treatment option.
PPIs are frequently used off-label and are easily accessible as over-the-counter products, contributing to the potential for adverse events or drug-drug interactions.
Because primary pancreatic lymphoma is a rare disease, optimal diagnostic and therapeutic protocols have not yet been established.